Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age50-80
SponsorAssiut University

About this trial

The study aims to evaluate the role of TRUS in improving the efficacy and safety of endoscopic enucleation of prostate and TURP.

Eligibility criteria

Qualifiers

Male patients aged 50-80 years

Diagnosed with benign prostatic hyperplasia (BPH) and scheduled for TURP or prostatic adenoma enucleation.

The patients have clear indication for endoscopic surgery (according to the guidelines).

Clinically fit patients for surgery.

Disqualifiers

• Prostate cancer

Previous urethral or prostate surgery

Neurogenic bladder

Urethral stricture

Trial design

Treatments tested in this trial

  • TRUS-Guided TURP and enucleation
  • Standard TURP and enucleation

Treatment groups

114 Participants
are divided into 2 treatment groups

Sponsors and collaborators